Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast CancerKunal C. Kadakia, N. Lynn Henry, David A. Flockhart et al.|The Oncologist|2016Cited by 76
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancerDaniel L. Hertz, James M. Rae, Kelley M. Kidwell et al.|The Pharmacogenomics Journal|2016Cited by 25